Skip to main content
Medical information Clinical review pending

Genetic Testing

CYP1A2 Gene Cytochrome P450 Deficiency Genetic Test

Understand how your body processes certain medications with the CYP1A2 Gene Cytochrome P450 Deficiency test. This genetic test analyzes variations in the CYP1A2 gene, which affects drug metabolism. Ideal for personalized medicine and managing potential drug reactions.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample, Extracted DNA, or One drop of blood on an FTA card.
Results
Confirm with the laboratory before booking.
Preparation
A genetic counseling session is recommended before the test to discuss family history and the clinical context. Please confirm specific preparation requirements with the laboratory before booking.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the CYP1A2 Gene Cytochrome P450 Deficiency Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Family history of metabolic disorders.
  • ✓Experiencing adverse reactions to medications.
  • ✓Taking medications metabolized by the CYP1A2 enzyme.
  • ✓Seeking personalized medicine approaches.
  • ✓Genetic counseling for treatment planning.
02

In plain language

What this test helps you understand

This test helps identify genetic variations in the CYP1A2 gene that may affect drug metabolism. It can aid healthcare providers in understanding potential risks for adverse drug reactions and guide personalized medication management.
The CYP1A2 Gene Cytochrome P450 Deficiency NGS Genetic DNA Test uses advanced Next Generation Sequencing (NGS) technology to examine your CYP1A2 gene. This gene is vital for breaking down various drugs and environmental substances. Knowing your specific genetic variations can help predict how your body handles certain medications, potentially leading to safer and more effective treatments. This test identifies genetic variants that might indicate altered activity of the cytochrome P450 enzyme, which is important for metabolizing drugs like caffeine and some antidepressants. Understanding your genetic profile allows for more informed decisions about medication choices and dosages, tailored to your individual needs.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationA genetic counseling session is recommended before the test to discuss family history and the clinical context. Please confirm specific preparation requirements with the laboratory before booking.
SampleBlood sample, Extracted DNA, or One drop of blood on an FTA card.
MethodologyNext Generation Sequencing (NGS) is used to analyze the CYP1A2 gene for specific genetic variations.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes specific variants within the CYP1A2 gene. It does not assess all possible genetic factors influencing drug metabolism or overall health. Results should be interpreted in conjunction with clinical information and other relevant tests. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

The CYP1A2 gene provides instructions for making an enzyme that helps break down (metabolize) certain drugs and chemicals in the body.
Understanding variations in your CYP1A2 gene can help predict how your body processes specific medications, potentially leading to safer and more effective treatment.
Individuals with a family history of metabolic issues, those experiencing adverse drug reactions, or those taking medications metabolized by CYP1A2 may benefit.
Results indicate genetic variations. A healthcare provider or genetic counselor can help interpret these results in the context of your health history and medication use.
A blood sample, extracted DNA, or a single drop of blood on an FTA card is required.
Turnaround time varies. Please confirm the current estimated timeframe with the laboratory before booking.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp